Technical Analysis for THOR - Synthorx, Inc.

Grade Last Price % Change Price Change
grade C 67.99 0.00% 0.00
THOR closed unchanged on Wednesday, January 22, 2020, on 1.52 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down
Historical THOR trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish -0.06%
1,2,3 Pullback Bullish Bullish Swing Setup -0.06%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.06%
Pocket Pivot Bullish Swing Setup -0.06%
Calm After Storm Range Contraction -0.06%
Narrow Range Bar Range Contraction -0.06%
Outside Day Range Expansion -0.06%
Wide Bands Range Expansion -0.06%
Overbought Stochastic Strength -0.06%
New 52 Week Closing High Bullish 0.21%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company was founded based on important discoveries in Dr. Floyd Romesberg’s lab at The Scripps Research Institute. The company is headquartered in La Jolla, Calif.
Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immune System Tumor Genetics Autoimmune Disorders Platform Technology DNA Immune Checkpoint Molecular Genetics Nucleic Acids Genetic Code

Is THOR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 71.9
52 Week Low 11.05
Average Volume 460,667
200-Day Moving Average 23.82
50-Day Moving Average 48.43
20-Day Moving Average 69.31
10-Day Moving Average 68.54
Average True Range 1.19
ADX 67.07
+DI 48.03
-DI 13.05
Chandelier Exit (Long, 3 ATRs ) 68.32
Chandelier Exit (Short, 3 ATRs ) 71.14
Upper Bollinger Band 71.58
Lower Bollinger Band 67.04
Percent B (%b) 0.21
BandWidth 6.55
MACD Line 4.48
MACD Signal Line 6.35
MACD Histogram -1.8636
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 68.02
Resistance 3 (R3) 68.02 68.02 68.02
Resistance 2 (R2) 68.02 68.01 68.02 68.01
Resistance 1 (R1) 68.00 68.00 68.00 68.00 68.01
Pivot Point 68.00 68.00 68.00 68.00 68.00
Support 1 (S1) 67.98 67.99 67.98 67.98 67.97
Support 2 (S2) 67.98 67.98 67.98 67.97
Support 3 (S3) 67.96 67.98 67.97
Support 4 (S4) 67.96